61. Miao, Y., Zhang, Y., Chen, Y., Chen, L. & Wang, F. GABARAP is overexpressed in colorectal carcinoma and
correlates with shortened patient survival. Hepatogastroenterology 57, 257–261 (2010).
0. 62.
PubMed
Fujii, S. et al. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome.
Cancer Sci. 99, 1813–1819 (2008).
0. 1. 2. 3. 63.
CAS ISI PubMed Article
Wei, H. et al. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev.
25, 1510–1527 (2011).
0. 1. 2. 64.
CAS PubMed Article
Lock, R. et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol.
Cell 22, 165–178 (2011).
0. 1. 2. 3. 65.
CAS ISI PubMed Article
Kim, M.J. et al. Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. J. Biol.
Chem. 286, 12924–12932 (2011).
0. 1. 2. 3. 66.
CAS ISI PubMed Article
Guo, J.Y. et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis.
Genes Dev. 25, 460–470 (2011).
0. 1.
CAS ISI
2. 3. 67. 0. 1. 2. 3. 68.
PubMed Article
Yang, S. et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 25, 717–729 (2011).
CAS ISI PubMed Article
Sheen, J.H., Zoncu, R., Kim, D. & Sabatini, D.M. Defective regulation of autophagy upon leucine deprivation
reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 19, 613–628 (2011).
0. 1. 2. 69.
CAS PubMed Article
Cheong, H., Lindsten, T., Wu, J., Lu, C. & Thompson, C.B. Ammonia-induced autophagy is independent of
ULK1/ULK2 kinases. Proc. Natl. Acad. Sci. USA 108, 11121–11126 (2011).
0. 1. 70.
PubMed Article
Eng, C.H., Yu, K., Lucas, J., White, E. & Abraham, R.T. Ammonia derived from glutaminolysis is a diffusible
regulator of autophagy. Sci. Signal. 3, ra31 (2010).
0. 1. 2. 71.
CAS PubMed Article
Weinberg, F. et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated
tumorigenicity. Proc. Natl. Acad. Sci. USA 107, 8788–8793 (2010).
0. 1. 2. 72.
ADS PubMed Article
Kroemer, G. & Levine, B. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 9,
1004–1010 (2008).
0. 1.
CAS ISI
2. 3. 73.
PubMed Article
Lu, Z. et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian
cancer cells. J. Clin. Invest. 118, 3917–3929 (2008).
0. 1. 2. 74.
(2007). 0. 1. 2. 3. 75. 0. 1. 2. 3. 76.
CAS ISI PubMed
Mathew, R., Karantza-Wadsworth, V. & White, E. Role of autophagy in cancer. Nat. Rev. Cancer 7, 961–967
CAS ISI PubMed Article
Chen, N. & Karantza, V. Autophagy as a therapeutic target in cancer. Cancer Biol. Ther. 11, 157–168 (2011).
CAS ISI PubMed Article
Janku, F., McConkey, D.J., Hong, D.S. & Kurzrock, R. Autophagy as a target for anticancer therapy. Nat.
Rev. Clin. Oncol. 8, 528–539 (2011).
0. 1. 2. 3. 77.
CAS ISI PubMed Article
Poole, B. & Ohkuma, S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J.
Cell Biol. 90, 665–669 (1981).
0. 1. 2.
CAS ISI PubMed
3. 78.
Article
Amaravadi, R.K. et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of
lymphoma. J. Clin. Invest. 117, 326–336 (2007).
0. 1. 2. 3. 79.
CAS ISI PubMed Article
Maclean, K.H., Dorsey, F.C., Cleveland, J.L. & Kastan, M.B. Targeting lysosomal degradation induces
p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J. Clin. Invest. 118, 79–88 (2008).
0. 1. 2. 3. 80.
(2009). 0. 1. 2. 3. 4. 81.
CAS ISI PubMed Article
Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–714
CAS ADS ISI PubMed Article
Ward, P.S. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic
enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225–234 (2010).
0. 1. 2. 3. 82.
CAS ISI PubMed Article
Yazbeck, V.Y. et al. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces
autophagy and synergizes with vorinostat in mantle cell lymphoma. Exp. Hematol. 36, 443–450 (2008).
0. CAS
